EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Four decades of the RET gene: From discovery to tumor-agnostic therapy

Masahide Takahashi

Journal of the Formosan Medical Association · 2025

DOI: 10.1016/j.jfma.2025.06.033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the Formosan Medical Association, 2025. Verfasst von Masahide Takahashi. Beteiligte Einrichtung: International Center for Cell and Gene Center, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192, Japan. Electronic addr…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-ret, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The physiological and disease-related roles of the Rearranged during Transfection (RET) gene have been extensively studied since its discovery four decades ago. RET encodes a receptor tyrosine kinase whose ligands are members of the glial cell line-derived neurotrophic factor (GDNF) family. Unlike other receptor tyrosine kinase ligands, GDNF family ligands (GFLs) do not bind to RET directly; instead, RET requires GDNF family receptor αs (GFRαs) as coreceptors for their binding. The resulting GFL/GFRα/RET ternary complex plays physiologically crucial roles in developing some organ systems. RET alterations cause various human cancers and developmental disorders. Gene rearrangements occur in 5-20 % of papillary thyroid carcinoma, 1-2 % of non-small cell lung carcinoma, and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-retNeoplasmsHumansThyroid NeoplasmsProtein Kinase InhibitorsGlial Cell Line-Derived Neurotrophic Factor ReceptorsGlial Cell Line-Derived Neurotrophic Factor

Stichwörter der Autor:innen

Glial cell line-derived neurotrophic factor family ligandsRET geneRET kinase inhibitorsTumor-agnostic therapy

Substanzen

Proto-Oncogene Proteins c-retRET protein, humanProtein Kinase InhibitorsGlial Cell Line-Derived Neurotrophic Factor ReceptorsGlial Cell Line-Derived Neurotrophic Factor

Autor:innen und Institutionen

  • International Center for Cell and Gene Center, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192, Japan. Electronic address: masahide.takahashi@fujita-hu.ac.jp.

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology

Zitieren

APA

Takahashi, M. (2025). Four decades of the RET gene: From discovery to tumor-agnostic therapy. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2025.06.033

Vancouver

Takahashi M. Four decades of the RET gene: From discovery to tumor-agnostic therapy. Journal of the Formosan Medical Association. 2025. doi:10.1016/j.jfma.2025.06.033

BibTeX
@article{Takahashi2025,
  author = {Takahashi, Masahide},
  title = {Four decades of the RET gene: From discovery to tumor-agnostic therapy},
  journal = {Journal of the Formosan Medical Association},
  year = {2025},
  doi = {10.1016/j.jfma.2025.06.033}
}
Kostenlos starten →